Armenia Medical Device Registration Certificate: Suspension and Cancellation Rules
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The procedures for suspension and cancellation (invalidation) of registration certificates are written into the scope of Decision No. 46; in Armenia, both decisions may be adopted only by the Ministry of Health, and together with refusal of registration, reissuance of the certificate and amendments to the certificate they form part of the Ministry’s 6 statutory powers. The GRZAN conclusion: the direct market consequence of suspension or cancellation is that the product loses its legal right to circulate, and it also affects already issued import (compliance) certificates, because the import certificate relies heavily on the Armenian national registration status of the device.
2. Legal basis
| Regulation | Reference number | Publication date (entry into force) | Provision |
|---|---|---|---|
| Rules for the registration and examination of the safety, quality and effectiveness of medical devices | Decision No. 46 of the Council of the Eurasian Economic Commission, 2016-02-12 | Amended by Council Decision No. 144 of 2021-12-24 | Article 1 (suspension and cancellation); Article 16 |
| Ministry of Health of Armenia official page (State Registration of Medical Devices) | — | Current | List of Ministry of Health powers |
| Law of the Republic of Armenia on Medical Care and Services for the Population | No. ЗР-42 of 1996-03-04 | Amended by No. ЗР-504 of 2024-12-17 | Article 45; Chapter 10 |
| Rules for monitoring the safety, quality and effectiveness of medical devices | Decision No. 174 of the Board of the Eurasian Economic Commission, 2015-12-22 | 30 calendar days after the entry into force of the Agreement | Article 2; Article 3 |
3. Expert insights
Insight 1: The revised Article 1 lists suspension and cancellation among the procedures governed by the rules. The article provides that the procedures established by the rules include registration and examination, approval of expert opinions, resolution of disagreements, changes to the registration file (including the notification procedure), reissuance of registration certificates, approval of expert opinions for registered devices, and the suspension and/or cancellation (invalidation) of medical device registration certificates. GRZAN note: after the 2021 revision by Decision No. 144, the approval of expert opinions for registered medical devices is listed as an independent procedure, which means that even after certification a renewed approval of the expert opinion may be required — an additional maintenance obligation beyond suspension and cancellation.
Insight 2: The Armenian list of 6 powers. The official explanation of the Ministry of Health of Armenia states that the Ministry performs registration, refusal of registration, suspension of registration, cancellation of registration certificates, reissuance of registration certificates and amendments to registration certificates — 6 powers in total — based on expert opinions issued by the expert organization designated by a government decision. GRZAN note: all six powers are premised on the expert opinion, so the substantive battlefield against suspension or cancellation lies at the technical level of the SCDMTE, not at the administrative level.
Insight 3: Trigger situations are linked to surveillance results. Article 2 of Decision No. 174 lists the identification and prevention of the circulation of devices that do not meet the general safety and effectiveness requirements among the aims of surveillance; Article 3 provides that surveillance includes the collection, recording and analysis of adverse event (incident) information and the adoption of the relevant decisions. GRZAN note: the conclusions of post-market surveillance are an important input to suspension and cancellation, which is why the post-market system must be connected with the QMS.
Insight 4: Knock-on effect on import (compliance) certificates. Import of unregistered devices relies on proof of marketing in the country of origin or in an IMDRF member state; import of registered devices relies on a copy of the Armenian registration certificate. GRZAN note: once a registration certificate is cancelled, a registered device reverts to unregistered status and the import documentation requirements change accordingly; in addition, the refusal situation of an imported device lacking Armenian national registration under Article 47.2 applies again (except where the law provides otherwise; the provisions should be checked against the current text on arlis.am).
Insight 5: The three-stage response structure, as applied by GRZAN.
| Stage | Action | Key point |
|---|---|---|
| Prevention | Post-market system linked with the QMS | Establish surveillance under Decision No. 174; maintain the QMS under Decision No. 106 |
| Response | Technical engagement with the SCDMTE | Submit technical rebuttal and remediation evidence against the expert opinion |
| Disposition | Administrative engagement with the Ministry of Health | Assert the corresponding claims against the suspension or cancellation decision, and adjust import and sales arrangements in parallel |
4. Practical recommendations
- Prevent first: most triggers of suspension and cancellation come from post-market surveillance and manufacturing inspections; run both as routine compliance activities.
- Technical rebuttal before administration: upon receiving an adverse signal, first submit technical rebuttal and remediation evidence to the SCDMTE, then handle the administrative procedure.
- Assess the import impact in parallel: as soon as a suspension or cancellation occurs, immediately re-evaluate the import documentation requirements (whether the device has reverted to unregistered status).
- New post-certificate maintenance duty: monitor the approval of expert opinions for registered devices introduced by the 2021 revision and reserve response resources.
- Authorized representative readiness: under Decision No. 43 of 2026 the authorized representative may lead inspection coordination, and its responsiveness directly affects the outcome of the disposition.
5. Verification checklist
- □ Confirmed that suspension and cancellation procedures are written into Article 1 of Decision No. 46.
- □ Confirmed that the Ministry of Health of Armenia is the sole decision-making body and that the SCDMTE provides the expert opinion.
- □ Confirmed the new procedure for the approval of expert opinions for registered devices introduced in the 2021 revision.
- □ Established a linkage mechanism between post-market surveillance and the QMS.
- □ Prepared standard templates for technical rebuttal and remediation evidence.
- □ Assessed the knock-on effect of suspension and cancellation on import (compliance) certificate documentation.
- □ Confirmed the authorized representative’s duties in inspection coordination and remediation (Decision No. 43 of 2026).
Regulatory information verified as of October 30, 2026.
About GRZAN: GRZAN supports medical device manufacturers entering Armenia and the Eurasian Economic Union with regulatory registration, quality management systems, post-market surveillance and import clearance compliance. For inquiries, contact info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us